Literature DB >> 5098325

Effect of lactulose on cerebral metabolism in patients with chronic portosystemic encephalopathy.

I M James, M Garassini.   

Abstract

Cerebral blood flow and cerebral metabolism were studied in six patients with moderately severe portosystemic encephalopathy before and after a 10-day course of lactulose. As a result of therapy there was a mean increase in cerebral oxygen utilization but no changes in either mean glucose consumption or in mean cerebral blood flow. It appears therefore that the abnormalities in cerebral metabolism that have been previously described in patients with hepatic encephalopathy can be improved by the oral administration of lactulose.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5098325      PMCID: PMC1411795          DOI: 10.1136/gut.12.9.702

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  SIMPLE METHODS FOR THE DETERMINATION OF THE CONCENTRATIONS OF CARBON DIOXIDE AND OXYGEN IN BLOOD.

Authors:  R J LINDEN; J R LEDSOME; J NORMAN
Journal:  Br J Anaesth       Date:  1965-02       Impact factor: 9.166

2.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy.

Authors:  J B POSNER; F PLUM
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

3.  Cerebral metabolism in hepatic insufficiency.

Authors:  R W ALMAN; W R EHRMANTRAUT; J F FAZEKAS; H E TICKTIN
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

4.  Cerebral metabolism after portacaval shunt.

Authors:  E Polli; G Bianchi Porro; A T Maiolo
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

5.  Effect of induced metabolic alkalosis in hepatic encephalopathy.

Authors:  I M James; D Sampson; S Nashat; H S Williams; M Garassini
Journal:  Lancet       Date:  1969-11-22       Impact factor: 79.321

6.  The measurement of regional cerebral clearance rates in man using xenon-133 inhalation and extracranial recording.

Authors:  B L Mallett; N Veall
Journal:  Clin Sci       Date:  1965-08       Impact factor: 6.124

7.  Treatment of chronic portal-systemic encephalopathy with lactulose.

Authors:  J Bircher; J Müller; P Guggenheim; U P Haemmerli
Journal:  Lancet       Date:  1966-04-23       Impact factor: 79.321

8.  Ammonia in the upper gastrointestinal tract of man: quantitations and relationships.

Authors:  W H Summerskill; T Aoyagi; W B Evans
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

9.  Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis.

Authors:  S P Parbhoo; I M James; A Ajdukiewicz; C Xanalatos; J Kennedy; L J Chalstrey; P J Brock; P Sayer; S Sherlock
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

  9 in total
  5 in total

Review 1.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

3.  Treatment of chronic hepatic encephalopathy with levodopa.

Authors:  M Lunzer; I M James; J Weinman; S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

Review 4.  Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy-A Meta-Analysis.

Authors:  Peter N Bjerring; Lise L Gluud; Fin S Larsen
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

Review 5.  Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease.

Authors:  Annarein J C Kerbert; Rajiv Jalan
Journal:  F1000Res       Date:  2020-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.